The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Coronary Arteriosclerosis

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Coronary Arteriosclerosis


Psychiatry related information on Coronary Arteriosclerosis


High impact information on Coronary Arteriosclerosis


Chemical compound and disease context of Coronary Arteriosclerosis


Biological context of Coronary Arteriosclerosis


Anatomical context of Coronary Arteriosclerosis


Gene context of Coronary Arteriosclerosis


Analytical, diagnostic and therapeutic context of Coronary Arteriosclerosis


  1. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Watts, G.F., Lewis, B., Brunt, J.N., Lewis, E.S., Coltart, D.J., Smith, L.D., Mann, J.I., Swan, A.V. Lancet (1992) [Pubmed]
  2. Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene. Gaudet, D., Vohl, M.C., Perron, P., Tremblay, G., Gagné, C., Lesiège, D., Bergeron, J., Moorjani, S., Després, J.P. Circulation (1998) [Pubmed]
  3. Increased prevalence of coronary ectasia in heterozygous familial hypercholesterolemia. Sudhir, K., Ports, T.A., Amidon, T.M., Goldberger, J.J., Bhushan, V., Kane, J.P., Yock, P., Malloy, M.J. Circulation (1995) [Pubmed]
  4. Lipoprotein Lp(a) excess and coronary heart disease. Stein, J.H., Rosenson, R.S. Arch. Intern. Med. (1997) [Pubmed]
  5. Elevation of serum lipid levels during diuretic therapy of hypertension. Ames, R.P., Hill, P. Am. J. Med. (1976) [Pubmed]
  6. Effectiveness of statins in acute coronary syndromes. Foody, J.M., Nissen, S.E. Am. J. Cardiol. (2001) [Pubmed]
  7. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. Herrington, D.M., Reboussin, D.M., Brosnihan, K.B., Sharp, P.C., Shumaker, S.A., Snyder, T.E., Furberg, C.D., Kowalchuk, G.J., Stuckey, T.D., Rogers, W.J., Givens, D.H., Waters, D. N. Engl. J. Med. (2000) [Pubmed]
  8. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. Kuivenhoven, J.A., Jukema, J.W., Zwinderman, A.H., de Knijff, P., McPherson, R., Bruschke, A.V., Lie, K.I., Kastelein, J.J. N. Engl. J. Med. (1998) [Pubmed]
  9. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. Treasure, C.B., Klein, J.L., Weintraub, W.S., Talley, J.D., Stillabower, M.E., Kosinski, A.S., Zhang, J., Boccuzzi, S.J., Cedarholm, J.C., Alexander, R.W. N. Engl. J. Med. (1995) [Pubmed]
  10. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. Ludmer, P.L., Selwyn, A.P., Shook, T.L., Wayne, R.R., Mudge, G.H., Alexander, R.W., Ganz, P. N. Engl. J. Med. (1986) [Pubmed]
  11. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. Moliterno, D.J., Willard, J.E., Lange, R.A., Negus, B.H., Boehrer, J.D., Glamann, D.B., Landau, C., Rossen, J.D., Winniford, M.D., Hillis, L.D. N. Engl. J. Med. (1994) [Pubmed]
  12. Inefficacy of EDTA chelation therapy for coronary atherosclerosis. McGillem, M.J., Mancini, G.B. N. Engl. J. Med. (1988) [Pubmed]
  13. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. Schnyder, G., Roffi, M., Flammer, Y., Pin, R., Hess, O.M. JAMA (2002) [Pubmed]
  14. Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis. Laszik, Z.G., Zhou, X.J., Ferrell, G.L., Silva, F.G., Esmon, C.T. Am. J. Pathol. (2001) [Pubmed]
  15. Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment. Ruotolo, G., Båvenholm, P., Brismar, K., Eféndic, S., Ericsson, C.G., de Faire, U., Nilsson, J., Hamsten, A. J. Am. Coll. Cardiol. (2000) [Pubmed]
  16. Software and database for the analysis of mutations in the human LDL receptor gene. Varret, M., Rabès, J.P., Collod-Béroud, G., Junien, C., Boileau, C., Béroud, C. Nucleic Acids Res. (1997) [Pubmed]
  17. Heart rate variability and progression of coronary atherosclerosis. Huikuri, H.V., Jokinen, V., Syvänne, M., Nieminen, M.S., Airaksinen, K.E., Ikäheimo, M.J., Koistinen, J.M., Kauma, H., Kesäniemi, A.Y., Majahalme, S., Niemelä, K.O., Frick, M.H. Arterioscler. Thromb. Vasc. Biol. (1999) [Pubmed]
  18. Estrogen: consequences and implications of human mutations in synthesis and action. Grumbach, M.M., Auchus, R.J. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  19. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Yasue, H., Matsuyama, K., Matsuyama, K., Okumura, K., Morikami, Y., Ogawa, H. Circulation (1990) [Pubmed]
  20. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Vita, J.A., Treasure, C.B., Yeung, A.C., Vekshtein, V.I., Fantasia, G.M., Fish, R.D., Ganz, P., Selwyn, A.P. Circulation (1992) [Pubmed]
  21. Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies. Reis, S.E., Holubkov, R., Young, J.B., White, B.G., Cohn, J.N., Feldman, A.M. J. Am. Coll. Cardiol. (2000) [Pubmed]
  22. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). de Groot, E., Jukema, J.W., Montauban van Swijndregt, A.D., Zwinderman, A.H., Ackerstaff, R.G., van der Steen, A.F., Bom, N., Lie, K.I., Bruschke, A.V. J. Am. Coll. Cardiol. (1998) [Pubmed]
  23. Inhibition of ileal Na+/bile acid cotransporter by S-8921 reduces serum cholesterol and prevents atherosclerosis in rabbits. Higaki, J., Hara, S., Takasu, N., Tonda, K., Miyata, K., Shike, T., Nagata, K., Mizui, T. Arterioscler. Thromb. Vasc. Biol. (1998) [Pubmed]
  24. Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. Minamino, T., Kurihara, H., Takahashi, M., Shimada, K., Maemura, K., Oda, H., Ishikawa, T., Uchiyama, T., Tanzawa, K., Yazaki, Y. Circulation (1997) [Pubmed]
  25. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Erren, M., Reinecke, H., Junker, R., Fobker, M., Schulte, H., Schurek, J.O., Kropf, J., Kerber, S., Breithardt, G., Assmann, G., Cullen, P. Arterioscler. Thromb. Vasc. Biol. (1999) [Pubmed]
  26. Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease. Ye, S., Gale, C.R., Martyn, C.N. Eur. Heart J. (2003) [Pubmed]
  27. Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study. Chen, S., Tsybouleva, N., Ballantyne, C.M., Gotto, A.M., Marian, A.J. Pharmacogenetics (2004) [Pubmed]
  28. Clinical characteristics of double heterozygotes with familial hypercholesterolemia and cholesteryl ester transfer protein deficiency. Haraki, T., Inazu, A., Yagi, K., Kajinami, K., Koizumi, J., Mabuchi, H. Atherosclerosis (1997) [Pubmed]
  29. Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation. Eich, D.M., Nestler, J.E., Johnson, D.E., Dworkin, G.H., Ko, D., Wechsler, A.S., Hess, M.L. Circulation (1993) [Pubmed]
  30. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Egashira, K., Hirooka, Y., Kai, H., Sugimachi, M., Suzuki, S., Inou, T., Takeshita, A. Circulation (1994) [Pubmed]
  31. Early evidence of endothelial vasodilator dysfunction at coronary branch points. McLenachan, J.M., Vita, J., Fish, D.R., Treasure, C.B., Cox, D.A., Ganz, P., Selwyn, A.P. Circulation (1990) [Pubmed]
  32. The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study. Jukema, J.W., van Boven, A.J., Groenemeijer, B., Zwinderman, A.H., Reiber, J.H., Bruschke, A.V., Henneman, J.A., Molhoek, G.P., Bruin, T., Jansen, H., Gagné, E., Hayden, M.R., Kastelein, J.J. Circulation (1996) [Pubmed]
  33. Lipid-lowering trials in diabetes. Betteridge, D.J. Curr. Opin. Lipidol. (2001) [Pubmed]
WikiGenes - Universities